BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Prognosis
125 results:

  • 1. Superficial dedifferentiated liposarcoma: A clinicopathologic study.
    Bourgeau M; Gandhi JS; Deeb KK; Bahrami A
    Hum Pathol; 2024 Mar; 145():63-70. PubMed ID: 38423223
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database.
    Mochizuki T; Ikegami M; Akiyama T
    Cancer Sci; 2024 Feb; 115(2):575-588. PubMed ID: 38115234
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. sarcomas Harboring EWSR1::PATZ1 Fusions: A Clinicopathologic Study of 17 Cases.
    Dehner CA; Torres-Mora J; Gupta S; Kipp BR; Halling KC; Chen S; Warmke LM; Michal M; Alani A; Yu W; Kovacs K; Obeidin F; Iwenofu OH; Satturwar S; Meis JM; Folpe AL
    Mod Pathol; 2024 Feb; 37(2):100400. PubMed ID: 38043789
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Notch signaling regulates a metabolic switch through inhibiting PGC-1α and mitochondrial biogenesis in dedifferentiated liposarcoma.
    Tien PC; Chen X; Elzey BD; Pollock RE; Kuang S
    Oncogene; 2023 Aug; 42(34):2521-2535. PubMed ID: 37433985
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary cardiac sarcomas: A clinicopathologic study in a single institution with 25 years of experience with an emphasis on mdm2 expression and adjuvant therapy for prognosis.
    Cho H; Song IH; Jo U; Jeong JS; Koo HJ; Yang DH; Jung SH; Song JS; Cho KJ
    Cancer Med; 2023 Aug; 12(16):16815-16828. PubMed ID: 37395142
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Conundrum of Dedifferentiation in a Liposarcoma at a Peculiar Location: A Case Report and Literature Review.
    Ciongariu AM; Dumitru AV; Cîrstoiu C; Crețu B; Sajin M; Țăpoi DA; Ciobănoiu AD; Bejenariu A; Marin A; Costache M
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241198
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Intimal Sarcoma with mdm2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling.
    Giner F; Machado I; Rubio-Martínez LA; López-Guerrero JA; Claramunt-Alonso R; Navarro S; Ferrández A; Mayordomo-Aranda E; Llombart-Bosch A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108696
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical value of fluorescence
    Wang W; Li X; Liu P; Dong Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Brightline-1: phase II/III trial of the mdm2-p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS.
    Schöffski P; Lahmar M; Lucarelli A; Maki RG
    Future Oncol; 2023 Mar; 19(9):621-629. PubMed ID: 36987836
    [TBL] [Abstract] [Full Text] [Related]  

  • 10.
    Menon AA; Deshpande V; Suster D
    J Clin Pathol; 2023 May; 76(5):285-290. PubMed ID: 36898827
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.
    Jagosky MH; Anderson CJ; Symanowski JT; Steuerwald NM; Farhangfar CJ; Baldrige EA; Benbow JH; Livingston MB; Patt JC; Ahrens WA; Kneisl JS; Kim ES
    Cancer Med; 2023 Mar; 12(6):7029-7038. PubMed ID: 36464833
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Generation and characterization of patient-derived xenografts from patients with osteosarcoma.
    Chen F; Zhang Z; Shen R; Chen M; Li G; Zhu X
    Tissue Cell; 2022 Dec; 79():101911. PubMed ID: 36156374
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
    Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
    Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Clinicopathological characteristics and molecular alterations of primary cardiac leiomyosarcoma: report of five cases].
    Dong F; Chen D; Shang JF; Fang W; Han LY; Lian GL; Wang H; Zheng MH
    Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):512-517. PubMed ID: 35673722
    [No Abstract]    [Full Text] [Related]  

  • 15. Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients.
    Gan M; Zhang C; Qiu L; Wang Y; Bao H; Yu R; Liu R; Wu X; Shao Y; Hou P; Fei Z
    Cancer Med; 2022 Nov; 11(21):4070-4078. PubMed ID: 35586877
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Histopathological Correlation of Chromosome 12 Polysomy by Fluorescence in Situ Hybridization in Adipocytic Neoplasms.
    Wilcock DM; McMurtry V; Coleman JF; Kim JT; Khalili P; Deftereos G; Albertson D; Gulbahce EH; Liu T; Sirohi D
    Int J Surg Pathol; 2022 Oct; 30(7):734-742. PubMed ID: 35261272
    [No Abstract]    [Full Text] [Related]  

  • 17. Atypical spindle cell lipomatous tumour presenting as a large retroperitoneal mass - a case report and review of the literature.
    Krupinska M; León C; López Henríquez R; Vázquez BE; Rodríguez RNR; Marrero PM; Plasencia LD; Salido E
    Pol J Pathol; 2022; 73(4):364-370. PubMed ID: 36946274
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. What's new in adipocytic neoplasia?
    Thway K
    Histopathology; 2022 Jan; 80(1):76-97. PubMed ID: 34958506
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Improving Immunotherapy Efficacy in Soft-Tissue sarcomas: A Biomarker Driven and Histotype Tailored Review.
    Roulleaux Dugage M; Nassif EF; Italiano A; Bahleda R
    Front Immunol; 2021; 12():775761. PubMed ID: 34925348
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Larotrectinib in a Patient With Advanced Pleomorphic Liposarcoma of the Uterus.
    Valenciaga A; Iwenofu OH; Tinoco G
    J Natl Compr Canc Netw; 2021 Jul; 19(7):775-779. PubMed ID: 34340207
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.